Life sciences · Interventional Study
ClinicalTrials.gov · October 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07631247). This is a study registration, not published results. Lead sponsor: Dartmouth-Hitchcock Medical Center. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 15 participants (ESTIMATED). Conditions: Depression - Major Depressive Disorder. Interventions: OTHER: depression app for care partners of persons with dementia. Primary outcome measures: Usability of Intervention , Assessed after initial use of iPath app at T1 (2 weeks); Acceptability of Intervention , Assessed at end of study, T1 (2 weeks); Feasibility of Intervention , Assessed at end of study, T1 (2 weeks); Appropriateness of Intervention , Assessed at end of study, T1 (2 weeks); Treatment access , Assessed at end of study, T1 (2 weeks); Mental health literacy , Change between T0 and T1 (2 weeks). Brief summary: Depression is a significant problem in care partners of people living with dementia; despite the expansion of options for accessing evidence-based treatments, most care partners of people living with dementia are not screened for depression and do not receive treatment. The objective of this project is to identify a screening method for depression that is feasible and acceptable to care partners and to adapt an innovative pathway to online evidence-based treatment for depression (iPath\*D) as a means of increasing mental health literacy, screening rates and treatment access for care partners of people living with dementia. The results are expected to have a major positive impact by providing proof-of-principle for the use of an online pathway to evidence based treatment with the potential for reaching an unprecedented number of care partners who have unmet mental health needs.